PTC Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 11/13/2024 | 9.13 M | $338.54 M | 1.69% | 11.86% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.98 M | $296.18 M | 100.00% | 10.38% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 7.89 M | $292.82 M | -3.85% | 10.26% |
RTW INVESTMENTS, LP | 11/14/2024 | 7.39 M | $274.29 M | 0.00% | 9.61% |
ARMISTICE CAPITAL, LLC | 11/14/2024 | 7.23 M | $268.41 M | 3.92% | 9.41% |
COWEN AND COMPANY, LLC | 11/12/2024 | 3.59 M | $133.21 M | -4.41% | 4.67% |
CAMBER CAPITAL MANAGEMENT LP | 11/14/2024 | 3.50 M | $129.85 M | 0.00% | 4.55% |
STATE STREET CORP | 11/14/2024 | 2.90 M | $107.55 M | 5.44% | 3.77% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.87 M | $69.39 M | -37.27% | 2.43% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.80 M | $66.74 M | 0.61% | 2.34% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 1.49 M | $55.14 M | -13.38% | 1.93% |
D. E. SHAW & CO., INC. | 11/14/2024 | 1.42 M | $52.66 M | 4.56% | 1.85% |
FRANKLIN RESOURCES INC | 11/27/2024 | 1.41 M | $55.15 M | -4.17% | 1.83% |
MORGAN STANLEY | 11/14/2024 | 1.16 M | $42.96 M | -23.65% | 1.51% |
BLACKSTONE INC. | 11/14/2024 | 1.10 M | $40.64 M | 0.00% | 1.42% |
FMR LLC | 11/13/2024 | 1.06 M | $39.22 M | -4.25% | 1.37% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 822,441 | $30.51 M | 3.95% | 1.07% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 804,156 | $29.83 M | 17.13% | 1.05% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 706,730 | $26.22 M | 7.27% | 0.92% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 700,000 | $25.97 M | 0.00% | 0.91% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 660,532 | $24.51 M | -15.65% | 0.86% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 575,860 | $21.36 M | 2,056.78% | 0.75% |
JPMORGAN CHASE & CO | 12/26/2024 | 562,781 | $20.88 M | -17.35% | 0.73% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 559,746 | $20.77 M | -7.74% | 0.73% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 538,200 | $19.97 M | -34.21% | 0.70% |
JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 522,895 | $19.40 M | 0.00% | 0.68% |
ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2024 | 493,588 | $18.31 M | -1.11% | 0.64% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 492,464 | $18.27 M | 32.09% | 0.64% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/08/2024 | 472,288 | $17.52 M | 6.01% | 0.61% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 429,842 | $15.95 M | 10.35% | 0.56% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 355,069 | $13.33 M | -4.03% | 0.46% |
SQUAREPOINT OPS LLC | 11/14/2024 | 331,707 | $12.31 M | 169.92% | 0.43% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 317,297 | $11.77 M | -0.28% | 0.41% |
PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 315,041 | $11.69 M | -0.02% | 0.41% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 314,723 | $11.68 M | 1.24% | 0.41% |
PALO ALTO INVESTORS LP | 11/14/2024 | 264,469 | $9.81 M | 100.00% | 0.34% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 250,000 | $9.28 M | -16.67% | 0.33% |
CITADEL ADVISORS LLC | 11/14/2024 | 239,129 | $8.87 M | -11.46% | 0.31% |
JANE STREET GROUP, LLC | 11/15/2024 | 238,708 | $8.86 M | -30.17% | 0.31% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 232,239 | $8.62 M | -17.38% | 0.30% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 222,048 | $8.24 M | 132.15% | 0.29% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 219,464 | $8.14 M | -30.89% | 0.29% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 218,197 | $8.10 M | -21.81% | 0.28% |
TREXQUANT INVESTMENT LP | 11/12/2024 | 217,999 | $8.09 M | -26.95% | 0.28% |
BANK OF MONTREAL /CAN/ | 11/13/2024 | 216,344 | $8.13 M | 293.48% | 0.28% |
ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 208,302 | $7.73 M | 0.00% | 0.27% |
PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 195,000 | $7.23 M | 100.00% | 0.25% |
AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 189,579 | $7.03 M | 175.10% | 0.25% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 189,233 | $7.02 M | 584.11% | 0.25% |
CANDRIAM S.C.A. | 11/13/2024 | 168,220 | $6.24 M | 100.00% | 0.22% |
PTC Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 277 institutional investors and hedge funds held shares of PTC Therapeutics, Inc.. The most heavily invested institutionals were:
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC: 0
SG Americas Securities, LLC: 0
VANGUARD GROUP INC: 9.13 M
BlackRock Funding, Inc. /DE: 7.98 M
WELLINGTON MANAGEMENT GROUP LLP: 7.89 M
RTW INVESTMENTS, LP: 7.39 M
102.46% of PTC Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 91.06 M shares in the last 24 months. This purchase volume represents approximately $4.00 B in transactions.